Composition: 1 ml of sterile solution contains; 0.1 ± 0.01 mg of CaCl2 and 10⁻¹⁰-10⁻¹¹ mg of the protein-peptide complex isolated from the fruiting body of the fungus Trotovik flake (Cerióporus squamósus).
The physiological effect of viorgon-39 is associated with the ability to restore the structure and functions of damaged biological membranes of cells and their receptors, as well as contribute to the restoration of impaired metabolism in cells and tissues. Pronounced anti-infective effect. General firming.
Recommendations for use. Viorgon-39 is recommended as a general strengthening agent that increases the body's non-specific resistance to infections. Apply for metabolic disorders in cells and tissues, chronic infectious diseases of the gastrointestinal tract, liver, respiratory system, urological, gynecological, endocrine diseases; pregnancy pathologies, including infectious, breast diseases.
Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.
Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.
A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.
The interval between the various viorgons is at least 10 minutes.